AI shows promise in caring for older adults, but evidence remains early

Artificial intelligence is increasingly being applied to the assessment, monitoring and care of older adults, and a new narrative review in Aging Clinical and Experimental Research maps where these tools are heading — and where they still fall short. The review, published on 27 October 2026, examines current and emerging applications of AI in common conditions and care needs associated with ageing, including hypertension, stroke, myocardial infarction, Parkinson’s disease, osteoporosis, sarcopenia and supportive care robotics.

Across these domains, the authors describe how AI-enabled analysis of electronic health records, electrocardiograms, imaging, video, wearable-sensor data and home-monitoring measurements may support earlier disease detection, more objective functional assessment, personalised risk prediction and treatment, and greater independence for older people. The review frames these as potential benefits spanning both population health and individual clinical practice, rather than established outcomes already achieved at scale.

Several specific technical directions stand out. Care robots, meanwhile, may assist with companionship, medication management and falls detection.

However, the review is notably cautious about the maturity of this evidence. Much of it remains based on selected datasets, proof-of-concept studies or controlled settings, meaning that performance demonstrated in curated research environments may not translate to the messy realities of routine care for older adults. The authors also identify algorithmic bias, limited representation of frail and multimorbid older adults, privacy, governance, interpretability, interoperability, user burden and workforce consequences as important barriers that must be addressed before widespread deployment.

Given these limitations, the review concludes that AI should complement rather than replace clinical judgement. Equitable implementation, the authors argue, will require representative datasets, rigorous external and prospective validation, transparent models, user-centred design and evaluation of clinically meaningful outcomes. Overall, the review describes potential benefits of AI in the care of older adults while emphasising that much of the evidence remains based on selected datasets, proof-of-concept studies or controlled settings, and that rigorous validation is still needed.

Subject of Research: Applications of artificial intelligence in the assessment, monitoring and care of older adults

Article Title: Artificial intelligence in an ageing population

Article References: Lim, S., O’Riordan, M., Dennison, B., Zaidi, I., Friedrich, M. U., Todd, O., Wong, D., Haeusler, K. G., Anand, A., Rizvi, A., Reid, A., & Fuggle, N. R. (2026). Artificial intelligence in an ageing population. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-026-03554-6

Image Credits: AI Generated

DOI: 10.1007/s40520-026-03554-6

Keywords: artificial intelligence, ageing, older adults, stroke, Parkinson's disease, osteoporosis, sarcopenia, care robotics, algorithmic bias, narrative review, hypertension, myocardial infarction